Statistics for The Impact of Waiving Confirmatory Efficacy Studies on Biosimilar Development Costs and Timelines: A Comparative Analysis of Adalimumab Biosimilars
Total visits
| views | |
|---|---|
| The Impact of Waiving Confirmatory Efficacy Studies on Biosimilar Development Costs and Timelines: A Comparative Analysis of Adalimumab Biosimilars | 8 |
Total visits per month
| views | |
|---|---|
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 8 |
File Visits
| views | |
|---|---|
| 23153452-1.pdf | 1 |
| C0E57A08-B7FB-11EF-8C3A-D5CCAB9BDA60.pdf | 1 |
| SACM-Dissertation.pdf | 1 |